Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH2/UH3 Clinical Trial Not Allowed)
HHS-NIH11
POSTED: 10/15/2024
UPDATED: 10/15/2024
DUE: 10/14/2026
Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) invites applications to support the validation of molecular/cellular/imaging markers (referred to as "markers" or...
Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH3 Clinical Trials Not Allowed)
HHS-NIH11
POSTED: 10/15/2024
UPDATED: 10/15/2024
DUE: 10/14/2026
Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) intends to accelerate the adoption and validation of molecular/cellular/imaging markers (referred to as "markers"...
Data Coordinating Center for NCCIH Multi-Site Investigator-Initiated Clinical Trials of Mind and Body Interventions (Collaborative U24 Clinical Trial Required)
HHS-NIH11
POSTED: 10/15/2024
UPDATED: 03/31/2025
DUE: 07/14/2026
This notice of funding opportunity (NOFO), utilizing the U24 grant funding mechanism, encourages applications for a collaborating Data Coordinating Center (DCC) application that accompanies an investi...
Emerging Global Leader Award (K43 Independent Clinical Trial Required)
HHS-NIH11
POSTED: 10/15/2024
UPDATED: 10/15/2024
DUE: 12/03/2026
This is a reissue of the Emerging Global Leader Program (K43) to align with the clinical trials policy.
Emerging Global Leader Award (K43 Independent Clinical Trial Not Allowed)
HHS-NIH11
POSTED: 10/15/2024
UPDATED: 10/15/2024
DUE: 12/03/2026
This Funding Opportunity Announcement (FOA) is designed specifically for applicants proposing research that does not involve leading an independent clinical trial, a clinical trial feasibility study, ...
Cancer Center Support Grants (CCSGs) for NCI-designated Cancer Centers (P30 Clinical Trial Optional)
HHS-NIH11
POSTED: 10/12/2021
UPDATED: 04/02/2025
DUE: 01/07/2026
This Funding Opportunity Announcement (FOA) invites applications for P30 Cancer Center Support Grants (CCSGs) to support NCI-designated Cancer Centers. CCSGs support three types of Cancer Centers: 1) ...
Revision Applications for Validation of Biomarker Assays Developed Through NIH-Supported Research Grants (R01 Clinical Trial Not Allowed)
HHS-NIH11
POSTED: 10/10/2024
UPDATED: 10/10/2024
DUE: 10/14/2026
Through this Notice of Funding Opportunity (NOFO) is to accelerate the pace of translation of NCI-supported methods/assays/technologies (referred to as "assays") to the clinic. Specifically, the focus...
Continuation or Revision of NIDCR Clinical Trial Planning and Implementation Cooperative Agreement (UH3 Clinical Trial Required)
HHS-NIH11
POSTED: 10/10/2024
UPDATED: 10/10/2024
DUE: 01/06/2028
To support competing renewal or competitive revision of ongoing clinical trials supported by the National Institute of Dental and Craniofacial Research (NIDCR)
Interventions to expand cancer screening and preventive services to ADVANCE health in populations that experience health disparities (R01, Clinical Trial Required)
HHS-NIH11
POSTED: 10/10/2024
UPDATED: 04/03/2025
DUE: 01/07/2027
The Office of Disease Prevention (ODP) and participating National Institutes of Health (NIH) Institutes, Centers, and Offices (ICs) are issuing this R01 to solicit applications to address barriers and...
Pilot Projects to Enhance the Human Virome Program (R03 Clinical Trials Not Allowed)
$2,000,000
HHS-NIH11
POSTED: 10/08/2026
UPDATED: 10/08/2026
DUE: 11/10/2026
The Common Fund Human Virome Program (HVP) aims to extensively and comprehensively characterize the "healthy" human virome (the collection of viruses that normally reside inside the human body without...